Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

2 Feb 2021 09:55

RNS Number : 7095N
Athelney Trust PLC
02 February 2021
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 256.2p at 31 January 2021.

Fund Manager's comment for January 2021

The renewed optimism at the beginning of the financial year was tempered by the announcement by the Prime Minister of a new nationwide lockdown that would once again have a negative impact on the economy which had been struggling to gather momentum in recent months. The impact of previous COVID lockdowns on the economy was clearly evident in recent economic data where December retail sales were only marginally up by 0.3% month-on-month after declining by 4.1% in November and November GDP fell 2.6% month-on-month, primarily due to a fall in service output of 3.4% and industrial output of 0.1%.

The MSCI declined by 1.1% during the month largely due to a weaker US market where the S&P500 also declined by 1.1% on the back of a loss of momentum toward the end of the quarter as economists forecast weaker trading conditions in the first quarter of this year. The FOMC left policy unchanged at its January meeting, keeping the federal funds rate unchanged at near zero while continuing to purchase Treasury securities and mortgage-backed securities. The other major markets performed poorly with the CAC down 2.9% and the DAX declining by 2.1%.

In the UK, markets reflected the sombre outlook for the economy with the FTSE 250 Index closing down by 1.3% over the month. The small cap stocks again performed better than large cap stocks with the Small Cap Index increasing by 0.2% as compared to the FTSE 100 Index which declined by 0.8%. The AIM All Share Index increased by 0.3% while the Fledgling Index was the best performer, increasing by 1.7% during the month.

In spite of a continuing sector rotation between growth and value, our growth-oriented portfolio increased by 0.6%. After allowing for expenses, the NAV increased by 0.4% over the month, an excellent result given current circumstances and market conditions. As we await company announcements on current trading, we have decided to remain fully invested, making no changes to our existing positions during January with cash comprising 3.5% of the portfolio at month end.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "Portfolio Details".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (licence no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has over AU$1500m under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD50m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD25m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD25m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP5m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 20/03/2018). See link

www.theaic.co.uk/aic/news/press-releases/next-generation-of-dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGCGDDUUGDGBD
Date   Source Headline
4th Aug 20209:21 amRNSMajor Shareholding
28th Jul 20203:36 pmRNSHalf-year Report
15th Jul 20202:14 pmRNSMajor Shareholding
15th Jul 20201:27 pmRNSHolding(s) in Company
15th Jul 20201:24 pmRNSMajor Shareholding
2nd Jul 202012:11 pmRNSNet Asset Value(s)
3rd Jun 20208:35 amRNSNet Asset Value(s)
4th May 20209:32 amRNSNet Asset Value(s)
8th Apr 20204:43 pmRNSAGM Statement
2nd Apr 20209:42 amRNSNet Asset Value(s)
24th Mar 20202:57 pmRNSAGM amendment
11th Mar 20208:23 amRNSDirector/PDMR Shareholding
10th Mar 20202:18 pmRNSHolding(s) in Company
3rd Mar 202010:01 amRNSNet Asset Value(s)
2nd Mar 202011:16 amRNSAnnual Financial Report
5th Feb 20201:21 pmRNSNet Asset Value(s)
3rd Jan 20209:49 amRNSNet Asset Value(s)
4th Dec 201911:05 amRNSNet Asset Value(s)
26th Nov 201910:43 amRNSMajor Shareholder Announcement
26th Nov 201910:43 amRNSHolding(s) in Company
26th Nov 201910:41 amRNSHolding(s) in Company
7th Nov 20191:32 pmRNSHolding(s) in Company
6th Nov 20192:04 pmRNSHolding(s) in Company
5th Nov 20199:13 amRNSNet Asset Value(s)
17th Oct 201912:08 pmRNSAppointment of Alternate Director
3rd Oct 201910:14 amRNSNet Asset Value(s)
5th Sep 201910:04 amRNSNet Asset Value(s)
2nd Aug 20198:21 amRNSNet Asset Value(s)
26th Jul 20191:41 pmRNSHalf-year Report
17th Jul 201910:39 amRNSHolding(s) in Company
17th Jul 201910:20 amRNSDirector notification
12th Jul 20192:20 pmRNSMajor Share Movement
2nd Jul 201912:53 pmRNSNet Asset Value(s)
17th Jun 20191:04 pmRNSDirectors Award
5th Jun 201911:57 amRNSNet Asset Value(s)
2nd May 20199:34 amRNSNet Asset Value(s)
15th Apr 20197:00 amRNSDirectorate Change
5th Apr 201911:16 amRNSNet Asset Value(s)
4th Apr 20197:52 amRNSResult of AGM
29th Mar 20199:20 amRNSHolding(s) in Company
27th Mar 20194:12 pmRNSAmendment to the Chairmans letter re Notice of AGM
20th Mar 20197:00 amRNSBoard Letter to Shareholders
18th Mar 20199:05 amRNSLetter to Shareholders
14th Mar 20198:59 amRNSHolding(s) in Company
6th Mar 20191:52 pmRNSAnnual Financial Report - Amendment
5th Mar 20198:29 amRNSAnnual Financial Report
4th Mar 201912:12 pmRNSNet Asset Value(s)
11th Feb 20197:00 amRNSDirectorate Change
6th Feb 201910:30 amRNSNet Asset Value(s)
25th Jan 20191:37 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.